Martingale Asset Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Martingale Asset Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,987	Closed	-$836K	–	865
2023 Q2	$836K	Sell	17,987 -6,967	-28%	-$241K	0.02%	493
2023 Q1	$715K	Buy	+24,954	New	+$739K	0.01%	530

Martingale Asset Management's DICE Position: Q3 2023 in Review

Martingale Asset Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 17,987 shares — an estimated $836K sold.

Martingale Asset Management first reported a position in DICE in Q1 2023 and held it in 2 quarters. The position peaked at $836K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Martingale Asset Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Martingale Asset Management sold 17,987 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $836K.
Martingale Asset Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Martingale Asset Management's DICE Therapeutics, Inc. Common Stock position peaked at $836K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Martingale Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.